APOTEX CORP FDA Approval ANDA 091300

ANDA 091300

APOTEX CORP

FDA Drug Application

Application #091300

Application Sponsors

ANDA 091300APOTEX CORP

Marketing Status

Prescription001

Application Products

001TABLET;ORAL50MG0RILUZOLERILUZOLE

FDA Submissions

ORIG1AP2013-06-18
LABELING; LabelingSUPPL4AP2021-09-08STANDARD

Submissions Property Types

ORIG1Null7
SUPPL4Null15

TE Codes

001PrescriptionAB

CDER Filings

APOTEX CORP
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91300
            [companyName] => APOTEX CORP
            [docInserts] => ["",""]
            [products] => [{"drugName":"RILUZOLE","activeIngredients":"RILUZOLE","strength":"50MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"RILUZOLE","submission":"RILUZOLE","actionType":"50MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.